Skip to main content

Peer Review reports

From: First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis

Original Submission
19 May 2018 Submitted Original manuscript
24 Oct 2018 Reviewed Reviewer Report - Sara Lonardi
4 Jan 2019 Reviewed Reviewer Report - Reviewer 2
21 Jan 2019 Author responded Author comments - Bobo Zheng
Resubmission - Version 2
21 Jan 2019 Submitted Manuscript version 2
20 Feb 2019 Reviewed Reviewer Report - Sara Lonardi
5 Mar 2019 Author responded Author comments - Bobo Zheng
Resubmission - Version 3
5 Mar 2019 Submitted Manuscript version 3
Publishing
15 Mar 2019 Editorially accepted
28 Mar 2019 Article published 10.1186/s12885-019-5481-z

You can find further information about peer review here.

Back to article page